
Weight-loss jabs may need to be taken for life, experts warn
The drugs are sold under brand names like Mounjaro and Wegovy and work by reducing food cravings.
Obese patients can currently be prescribed the jabs on the NHS after being referred to specialist weight loss clinics, which are usually located in hospitals.
Hundreds of thousands of people also access the medication privately at pharmacies.
There have been warnings about buying potentially unsafe jabs online from unregulated retailers and potentially missing out on wraparound support.
Experts said the jabs should not be seen as the first option in weight loss and should be used in conjunction with lifestyle changes, such as eating more healthily and increasing exercise.
Professor Graham Easton, a GP who has been using weight loss jabs himself, said: 'I think it's a major issue about the proper funding and resourcing of not only the GPs in the surgeries but also the wraparound care we talked about.
'I think the other issue is that so far, to my knowledge, the NHS and National Institute for Health and Care Excellence have talked about this being something you take for two years, and that's probably related to data from research studies.
'But as we discussed, this is likely to be a lifelong commitment if it is going to be worthwhile to the NHS.
'There's no point in most people taking it for a couple of years and then have the weight bouncing back.
'You can argue possibly you're about to prepare for surgery or something, but in most cases it doesn't make any sense.
'Then I think there's a big issue around access. Most obesity occurs in poorer populations as wealthier populations tend to not be so affected.
'There's a massive sort of socio-economic inequality and there is a worry about this driving that inequality even further.
'Unless the NHS makes sure that these are available across the board equally, I think that's a major risk.'
Prof Easton said recent studies had shown people who stopped taking the drugs had put the weight they lost back on within around a year.
'That's often true of any diet, people would say, and that's certainly my experience of having wrestled with my weight in diets over the years,' he said.
'All I would say that I found interesting from that review was that they were suggesting perhaps that weight returns even quicker after having been on GLP-1 drugs.
'Then speculating, because there was no way of knowing from that review, that perhaps it's because people are not changing the behaviours we've been talking about like exercise and other lifestyle changes, just relying on the drugs.
'When you stop them, of course, you're going to put weight back on. The switch is turned back off, or whatever it was.
'I mean very similar to, for example, statins or anti-hypertensive blood pressure medications, if you want lifelong effects, you have to keep on them lifelong.'
Prof Easton was speaking at an event at the Cheltenham Science Festival discussing the growing use of weight loss drugs with neurophysiologist Dr Simon Cork and consultant endocrinologist and obesity expert Dr Tony Goldstone.
Hundreds of thousands of people access weight-loss medication privately (PA)
Dr Cork said the jabs have an important role to play in losing weight but are part of wider changes to diet and lifestyle.
'I think we have to understand that diet is always limited. People will tend to lose on average around 5% of their body weight on a diet,' he said.
'But you're hungry, you're miserable, you're tired, your wife hates you because you're so grumpy, you're not going to continue with that.
'But we should absolutely all be looking at our diet and all changing our diet, and doing something.'
Dr Goldstone said weight loss drugs had been used in the treatment of diabetes for over a decade and had benefits of reducing the risk of developing other conditions.
'We're now in the third and fourth generation of these drugs, but the first generation of these drugs we've been using for 15 years for diabetes,' he said.
'There is nothing of concern that has emerged. In fact, all we're seeing are benefits. I'm not too worried about longer term side effects coming out.
'There is no real biological reason why there should be dangerous side-effects in the way that we know these drugs work.
'The benefits of the weight loss improvement in the diabetes are actually by themselves helping health and preventing other diseases, like cancer, heart attacks, renal failure, and potentially even reducing the risk of Alzheimer's disease.
'All those benefits, even if there was something that we hadn't really thought of that emerged down the line, I suspect that the harm of that is outweighed by the potential benefits of weight loss improvement in diabetes control.'
Dr Cork said no drug is without side-effects and previous weight loss medications had failed because of them.
'There are side-effects, there are some concerning side-effects that tend to be very rare, but then you can monitor for those side-effects,' he said.
'As long as you're getting the correct care, as long as your GP is aware that you're taking them, then those should be identified.
'If you do find those side-effects, you can stop taking the drug.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Telegraph
an hour ago
- Telegraph
NHS spent £100 million on post last year
The NHS spent at least £102 million on posting letters last year despite pledging to go digital because of unreliable deliveries. The amount spent on sending mail, which can regularly arrive late and cause missed appointments, was up by 12.5 per cent on the year before, according to new research by the Taxpayers' Alliance. The research results have been released as the health service is about to get £30 billion more over three years in Rachel Reeves's spending review this week, to the detriment of other public services. They also revealed the NHS could make major savings in electricity and laundry costs, as well as reducing the eight million missed appointments that occur each year. The Telegraph previously revealed that the Royal Mail was introducing a new NHS barcode to cut late deliveries and the risk of missed appointments. But health officials have also pledged to do more to communicate with patients online and through the NHS app. Last week, the Department of Health said the app would become the default method of communication for patients seeking appointment reminders, screening invitations and test results as part of a major investment that would mean 50 million fewer letters are posted each year. The research from the Taxpayers' Alliance found that at least £102 million was spent in 2023-24 across 120 NHS hospital trusts, an average of £850,000 each. The researchers said this was a 'growing expense' with the costs rising by 12.5 per cent on the £90.3 million spent in 2022-23. Previous research found that as many as one in four of the eight million appointments that patients miss each year were because letters to patients arrived after the date of the planned appointment. Simon Cook, a research fellow of the Taxpayers' Alliance, said the public 'expect the NHS to double down on cutting any inefficient and wasteful expenditure'. 'With the health service facing financial pressures, there are huge savings to be made through simple, common sense changes,' he said. 'Ministers must recognise that sometimes the biggest savings don't always require major reforms, just the will to act.' The research paper also found that the NHS could save more than £150 million on electricity costs if it utilised its buying power. It said the average cost of electricity across NHS trusts in England was 30.5p per kWh in 2023-24, which was 'typically the rate that medium-sized businesses pay'. £154m potential laundry savings The NHS is the biggest single employer in Europe and 'if every NHS trust paid the average extra-large non-domestic consumer price of 22.6p, the saving would amount to £154 million in 2023-24,' the researchers said. The researchers also found significant discrepancies across the country in the amount being spent on laundry. While the NHS spent £270 million to launder 555 million items at an average cost of 48.7p per item, some areas achieved lower costs of 25p per item, while others spent £1.20. A Department of Health and Social Care spokesman said: 'This government inherited a broken NHS with wasteful spending, in desperate need of reform. 'Yesterday, we announced major investment in the NHS app to turbocharge our digital revolution – saving hundreds of millions in taxpayers' money spent on stamps and envelopes, and enabling push notifications and reminders to help cut missed appointments. We are also cutting NHS energy bills through solar power and renewable energy – delivering further savings for the taxpayer. 'Through our Plan for Change, we are reforming the NHS to ensure that every penny is spent on what matters most.' An NHS England spokesman said: 'Millions of patients are already receiving appointment reminders, screening invitations, and test results direct to their smartphones from the NHS, saving millions of pounds, avoiding the need for letters and freeing-up resources for patient care. 'People without access to smartphones and elderly patients will still receive messages through traditional routes such as letters to ensure they don't miss important information. 'The NHS is continually exploring ways to achieve the best possible value for taxpayers, including making targeted investment in technologies that can enable us to optimise our resources and boost productivity.'


BreakingNews.ie
2 hours ago
- BreakingNews.ie
Weight-loss jabs may need to be taken for life, experts warn
Weight-loss jabs may have to be used for many years if the long-term benefits to patients are to be realised, experts have said. The drugs are sold under brand names like Mounjaro and Wegovy and work by reducing food cravings. Advertisement Supply of the drugs is limited in Ireland, and mainly accessible to those who have been prescribed it by GPs or specialists. Hundreds of thousands of people also access the medication privately at pharmacies. There have been warnings about buying potentially unsafe jabs online from unregulated retailers and potentially missing out on wraparound support. Experts said the jabs should not be seen as the first option in weight loss and should be used in conjunction with lifestyle changes, such as eating more healthily and increasing exercise. Advertisement Professor Graham Easton, a GP who has been using weight loss jabs himself, said: 'I think it's a major issue about the proper funding and resourcing of not only the GPs in the surgeries but also the wraparound care we talked about. 'I think the other issue is that so far, to my knowledge, the NHS and National Institute for Health and Care Excellence have talked about this being something you take for two years, and that's probably related to data from research studies. 'But as we discussed, this is likely to be a lifelong commitment if it is going to be worthwhile to the NHS. 'There's no point in most people taking it for a couple of years and then have the weight bouncing back. Advertisement 'You can argue possibly you're about to prepare for surgery or something, but in most cases it doesn't make any sense. 'Then I think there's a big issue around access. Most obesity occurs in poorer populations as wealthier populations tend to not be so affected. 'There's a massive sort of socio-economic inequality and there is a worry about this driving that inequality even further. 'Unless the NHS makes sure that these are available across the board equally, I think that's a major risk.' Advertisement Prof Easton said recent studies had shown people who stopped taking the drugs had put the weight they lost back on within around a year. 'That's often true of any diet, people would say, and that's certainly my experience of having wrestled with my weight in diets over the years,' he said. 'All I would say that I found interesting from that review was that they were suggesting perhaps that weight returns even quicker after having been on GLP-1 drugs. 'Then speculating, because there was no way of knowing from that review, that perhaps it's because people are not changing the behaviours we've been talking about like exercise and other lifestyle changes, just relying on the drugs. Advertisement 'When you stop them, of course, you're going to put weight back on. The switch is turned back off, or whatever it was. 'I mean very similar to, for example, statins or anti-hypertensive blood pressure medications, if you want lifelong effects, you have to keep on them lifelong.' Prof Easton was speaking at an event at the Cheltenham Science Festival discussing the growing use of weight loss drugs with neurophysiologist Dr Simon Cork and consultant endocrinologist and obesity expert Dr Tony Goldstone. Hundreds of thousands of people access weight-loss medication privately (PA) Dr Cork said the jabs have an important role to play in losing weight but are part of wider changes to diet and lifestyle. 'I think we have to understand that diet is always limited. People will tend to lose on average around 5 per cent of their body weight on a diet,' he said. 'But you're hungry, you're miserable, you're tired, your wife hates you because you're so grumpy, you're not going to continue with that. 'But we should absolutely all be looking at our diet and all changing our diet, and doing something.' Dr Goldstone said weight loss drugs had been used in the treatment of diabetes for over a decade and had benefits of reducing the risk of developing other conditions. 'We're now in the third and fourth generation of these drugs, but the first generation of these drugs we've been using for 15 years for diabetes,' he said. 'There is nothing of concern that has emerged. In fact, all we're seeing are benefits. I'm not too worried about longer term side effects coming out. 'There is no real biological reason why there should be dangerous side-effects in the way that we know these drugs work. 'The benefits of the weight loss improvement in the diabetes are actually by themselves helping health and preventing other diseases, like cancer, heart attacks, renal failure, and potentially even reducing the risk of Alzheimer's disease. 'All those benefits, even if there was something that we hadn't really thought of that emerged down the line, I suspect that the harm of that is outweighed by the potential benefits of weight loss improvement in diabetes control.' Dr Cork said no drug is without side-effects and previous weight loss medications had failed because of them. 'There are side-effects, there are some concerning side-effects that tend to be very rare, but then you can monitor for those side-effects,' he said. 'As long as you're getting the correct care, as long as your GP is aware that you're taking them, then those should be identified. 'If you do find those side-effects, you can stop taking the drug.'


BBC News
2 hours ago
- BBC News
Hospitals to get £2.6m for 'urgent' infrastructure upgrades
Several hospitals are set to get upgrades after Nottinghamshire Healthcare NHS Foundation Trust has secured government will include improving fire safety systems, water infrastructure and electrical and energy systems at Rampton Hospital, The Wells Road Centre, Wathwood Hospital, Thorneywood Mount and Arnold Lodge improvements at the sites, which offer mental health and community services across the Midlands and South Yorkshire, are due to start in the summer with the aim of completing next Healthcare NHS Foundation Trust, which runs the hospitals, said the funding would support urgent projects and create a better environment for patients. The £2,595,000 grant is part of a national project to improve NHS buildings and infrastructure in Rampton High Secure Hospital and several others, it is hoped the money will allow a full upgrade of fire safety systems - including alarms, fire compartmentation and suppression Wells Road Centre in Mapperley, Nottingham, will benefit from the replacement of ageing at Arnold Lodge, in Leicester, a specialist secure unit, the money will deliver electrical and energy system improvements. The trust said planning work was under way to ensure the disruption was executive at the trust Ifti Majid said the funding was "fantastic news", adding: "It allows us to fast-track improvements that make our hospitals safer, greener and more welcoming places to receive care and to work."Alison Wyld, executive director of finance and estates, added: "By tackling our highest-risk infrastructure now, we're not only reducing future maintenance costs but also supporting the trust's net zero ambitions."